Sarina Anne Piha-Paul

Associate Professor

  • 4326 Citations
  • 30 h-Index
19972019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sarina Anne Piha-Paul is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Neoplasms Medicine & Life Sciences
Clinical Trials, Phase I Medicine & Life Sciences
Mutation Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Vascular Endothelial Growth Factor A Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

9 Citations (Scopus)

Advances in HER2-targeted therapy: Novel agents and opportunities beyond breast and gastric cancer

Meric-Bernstam, F., Johnson, A. M., Ileana Dumbrava, E. E., Raghav, K. P. S., Balaji, K., Bhatt, M., Murthy, R. K., Rodon Ahnert, J. & Piha-Paul, S. A., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2033-2041 9 p.

Research output: Contribution to journalReview article

Stomach Neoplasms
Breast Neoplasms
Therapeutics
Biliary Tract Neoplasms
Neoplasms
2 Citations (Scopus)

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers (Nature, (2018), 554, 7691, (189-194), 10.1038/nature25475)

Hyman, D. M., Piha-Paul, S. A., Won, H., Rodon, J., Saura, C., Shapiro, G. I., Juric, D., Quinn, D. I., Moreno, V., Doger, B., Mayer, I. A., Boni, V., Calvo, E., Loi, S., Lockhart, A. C., Erinjeri, J. P., Scaltriti, M., Ulaner, G. A., Patel, J., Tang, J. & 27 others, Beer, H., Selcuklu, S. D., Hanrahan, A. J., Bouvier, N., Melcer, M., Murali, R., Schram, A. M., Smyth, L. M., Jhaveri, K., Li, B. T., Drilon, A., Harding, J. J., Iyer, G., Taylor, B. S., Berger, M. F., Cutler, R. E., Xu, F., Butturini, A., Eli, L. D., Mann, G., Farrell, C., Lalani, A. S., Bryce, R. P., Arteaga, C. L., Meric-Bernstam, F., Baselga, J. & Solit, D. B., Feb 28 2019, In : Nature. 566, 7745, p. E11-E12

Research output: Contribution to journalComment/debate

Phosphotransferases
Neoplasms
1 Citation (Scopus)
Open Access
Internet
Observational Studies
Decision Making
Cross-Sectional Studies
Physicians

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: A phase 2, open-label, single-arm study

Piha-Paul, S. A., Taylor, M. H., Spitz, D., Schwartzberg, L., Beck, J. T., Bauer, T. M., Meric-Bernstam, F., Purkayastha, D., Karpiak, L., Szpakowski, S. & Braiteh, F., Jan 1 2019, In : Oncotarget. 10, 60, p. 6526-6535 10 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinase
Safety
Sarcoma
Neoplasms
Mutation